Stock Events

Stock Events

Regulus Therapeutics (RGLS) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.25

-0.21

-0.18

-0.15

Details

Expected EPS

-0.245

Actual EPS

-0.15

Surprise EPS

0.1

Surprise Percent

+38.78%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.15 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.